Tower Research Capital LLC (TRC) - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 77 filers reported holding ONCOCYTE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$11,453
+81707.1%
49,797
+30.2%
0.00%
Q1 2023$14
+180.0%
38,236
+125.5%
0.00%
Q4 2022$5
-100.0%
16,954
+25.5%
0.00%
Q3 2022$10,000
-23.1%
13,504
-7.9%
0.00%
Q2 2022$13,000
-43.5%
14,662
-5.2%
0.00%
Q1 2022$23,000
-23.3%
15,460
+12.1%
0.00%
-100.0%
Q4 2021$30,000
+15.4%
13,793
+89.8%
0.00%0.0%
Q3 2021$26,000
-29.7%
7,268
+11.5%
0.00%0.0%
Q2 2021$37,000
+146.7%
6,516
+123.8%
0.00%
Q1 2021$15,000
-53.1%
2,911
-78.3%
0.00%
-100.0%
Q4 2020$32,000
-56.8%
13,413
-74.9%
0.00%0.0%
Q3 2020$74,000
+335.3%
53,509
+522.0%
0.00%0.0%
Q2 2020$17,000
+6.2%
8,603
+33.3%
0.00%0.0%
Q1 2020$16,000
+300.0%
6,456
+314.9%
0.00%
Q4 2019$4,000
+100.0%
1,556
+81.4%
0.00%
Q3 2019$2,000858
+758.0%
0.00%
Q2 2019$0
-100.0%
100
-96.6%
0.00%
-100.0%
Q1 2019$12,000
+300.0%
2,956
+18.6%
0.00%
Q4 2018$3,0000.0%2,492
+101.9%
0.00%
Q1 2018$3,0000.0%1,234
+82.8%
0.00%
Q4 2017$3,000
-25.0%
675
-4.3%
0.00%
Q2 2017$4,0000.0%705
-2.2%
0.00%
Q1 2017$4,0000.0%721
-1.5%
0.00%
Q3 2016$4,000
-50.0%
732
-65.5%
0.00%
-100.0%
Q2 2016$8,000
+100.0%
2,119
+112.5%
0.00%0.0%
Q1 2016$4,0009970.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders